Eligible Patients To Be Granted Early Access To Oxbryta in UK
Oxbryta, which has been a daily oral therapy for the treatment of the haemolytic anaemia that has been associated with the sickle cell disease (SCD), and it has now been available to all the eligible patients across the United Kingdom under the early access program. The therapy has also received a positive scientific opinion by […]
Continue Reading